Comvita Limited · NZX:CVT

Comvita — FY2024 Earnings Presentation

40 slides from Comvita's earnings presentation, Aug 29, 2024

  1. Slide 1: Agility in Unpredictable Times

    Agility in PRESENTED BY: INVESTOR PRESENTATION FULL YEAR RESULT FY24 Unpredictable David Banfield, CEO Nigel Greenwood, CFO Brett Hewlett, Chair Times 29 AUGUST 2024

  2. Slide 2: Notice

    I M P O R TAN T Notice This presentation is given on behalf of Comvita They should not be used in substitution for, or which should not be regarded as a reliable Limited. Information in this presentation: isolation of, Comvita’s audited financial indicator of future performance; statements. We monit

  3. Slide 3: FY24 Financial Headlines

    FY24 Financial Headlines • Revenue $204.3M : -12.7% (-$28.9M) vs PCP (FY23: $234M) − Greater China market revenue -$19.2M or -17.6% vs PCP, GP impact -$15.3M vs PCP − US market revenue -$9.5M or -26.6% vs PCP, GP impact -$5.3M vs PCP • Gross profit 55% : -300bps vs PCP (FY23: 58%) • Non-cash impairm

  4. Slide 4: Summary

    FY24 Summary HEADLINES • Revenue and associated gross profit in key markets were hit by a combination of − General macro economic slowdown in our biggest market − Price competition in entry point segments of Mānuka honey − Mānuka honey contraction in our biggest market • Over supply from pre 2019 ha

  5. Slide 5: Our Response

    FY24 Our Response • Good and Better product range launched to target short term ‘value’ segment and expanded distribution • Value range launched in China market, April 2024 • Enhanced consumer education on Comvita quality and partnership with other high profile premium brands across Asia • Regional

  6. Slide 6: Income statement

    K E Y R E S U LT S Income statement FY24 For the year ended 30 June 30 June Commentary NZD 000s 2024 2023 Variance $ Variance % • Total revenue -$29.9M or -12.7% Revenue 204,341 234,195 (29,854) (12.7%) • China and North America combined -$28.7M Gross Profit % 55.0% 58.0% (3%) • SEA +$7.9M - offsett

  7. Slide 7: Impairment and Non-recurring Items

    FY24 Impairment and Non-recurring Items N O N - C A S H I M PA I R M E N T NON-RECURRING COSTS • Impairment test was indicated due to a material gap between the company’s net total assets (tangible and • Net profit after Tax of -$16.9M intangible) and its market capitalisation • Total non-recurring

  8. Slide 8: Reconciliation of Group Results

    K E Y R E S U LT S Reconciliation of Group Results R E P O R T E D T O U N D E R LY I N G F Y 2 4 Gross NZD 000s Revenue Profit EBITDA EBIT NPAT Reported Results 204,341 112,389 (59,651) (73,506) (77,388) Commentary • After adjusting for one off non trading Remove ERP* Costs 7,245 7,245 5,216 items

  9. Slide 9: Key Balance Sheet Items

    K E Y R E S U LT S Key Balance Sheet Items FY24 As at 30 June 30 June Commentary NZD 000s 2024 2023 Audited Audited Variance $ • Net debt $79.7M up $26.3M or +49.3% on PCP • HoneyWorld acquisition and Apiter investments Net Debt 79,707 53,386 26,321 debt funded ($9.8M) as well as lower operating Deb

  10. Slide 10: Inventory

    K E Y R E S U LT S Inventory FY24 As at 30 June 30 June NZD 000s Commentary 2024 2023 Audited Audited Variance $ Variance % • Inventory has decreased by $1.7M vs PCP Finished Goods 64,609 47,558 17,051 35.9%) • Raw materials decreased by $15.2M reflecting the benefits of unwinding the previous long

  11. Slide 11: Cashflow

    K E Y R E S U LT S Cashflow FY24 As at 30 June 30 June NZD 000s 2024 2023 Audited Audited Variance $ Commentary Operating Cash Inflow 5,333 8,083 (2,750) • Operating cashflow of $5.3M down $2.8M on Investing Activities (13,654) (20,754) (7,100) prior year predominantly due to lower earnings Financin

  12. Slide 12: Cost out target $10M-$15M vs FY24

    Cost out target $10M-$15M vs FY24 FY25 Savings Annualised Headcount Savings reduction vs FY24 COGS $2M- $5M $5M- $8M 22 Commentary • On track to deliver $5-10M cost savings in FY25 OPEX $3M - $5M $5M-$7M 31 and annualised savings of $10-$15M • Headcount to be reduced by 53 positions versus FY24 actu

  13. Slide 13: Challenges & Actions: High Inventory & Net Debt

    FY24 Challenges & Actions HIGH INVENTORY & NET DEBT The issue • Lower sales than forecast meant despite reducing NET DEBT Action to date Inventory held as raw materials cash is tied up in ✓ Increased in market activity to reduce finished good elevated finished goods in market preventing early pay do

  14. Slide 14: Segmental Performance

    FY24 Segmental Performance 14

  15. Slide 15: Sales and Gross Profit Impact

    FY24 Sales and Gross Profit Impact REVENUE -$28.8M : GP -$20.6M VS PCP GREATER CHINA NORTH AMERICA FY24 FY23 FY24 FY23 $ 89.8 M VS 109.0 $ M $ 26.1 M VS $ 35.6 M (-$19.2M or -17.6% vs PCP) (-$9.5M or -26.6% vs PCP) • Mainland China sales -23% or -$20M • North America sales -$9.5M • Impacted by parti

  16. Slide 16: Other Segments Full Year Performance

    OTHER SEGMENTS FULL YEAR PERFORM ANCE REPORTED+ CURRENCY AUSTRALIA NEW ZEALAND Vs. This Year Last Year Vs. Last Year Segment NZD 000s Jun-24 Jun-23 Last Year % • Rest of Asia sales up $5.3M or 16.6% Rest of Asia Sales 37,059 31,771 5,288 16.6% • Sales growth contributed by HoneyWorld acquisition. Ne

  17. Slide 17: China Market Dynamics

    FY24 China Market Dynamics • FY24 surprise contraction in China total honey market from July 2023 − All honey category* sales out -17.5% − Mānuka honey category* sales out -15.5% • Comvita FY24 Mānuka honey sales -20% like for like − Performance declined due to cancellation of major China shopping f

  18. Slide 18: Comvita Mānuka Honey Sales

    Comvita Mānuka Honey Sales* FY23 & FY24 M AT E R I A L D I S R U P T I O N D U R I N G T H R E E F E S T I VA L S Mānuka Honey Monthly Sales 11:11 Cancellation China New Cancellation of 6:18 Festival 12:12 Festival Year shopping Festival Commentary • Sales out up 1% for July to October 2023 (channel

  19. Slide 19: Greater China Full Year Performance

    GREATER CHINA FULL YEAR PERFORMANCE This Year Last Year Vs. Vs. NZD 000s Jun-24 Jun-23 Last Year Last Year % Sales 89,820 109,005 (19,185) (17.6%) Net Contribution 17,204 26,821 (9,617) (35.9%) Net Contribution % 19.2% 24.6% (5.4%) • Total segment revenue (19.2M) vs PCP impacted by Mainland China pe

  20. Slide 20: Premiumisation & Leadership in China

    FY24 Premiumisation & Leadership in China COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY24 20

  21. Slide 21: Regional New Product Development

    FY24 Regional New Product Development COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY24

  22. Slide 22: COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY24

    COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY24 22

  23. Slide 23: Challenges & Actions: China Market Demand

    FY24 Challenges & Actions CHINA MARKET DEMAND The issue Action to date CHINA HONEY • Abrupt change in consumer demand caused by: ✓ Harmonised pricing (offline : online), added focused MARKET REVENUE resource to enable more balanced distribution • General consumer confidence following macro economic

  24. Slide 24: North America Full Year Performance

    NORTH AMERICA FULL YEAR PERFORMANCE This Year Last Year Vs. Vs. NZD 000s Jun-24 Jun-23 Last Year Last Year % Sales 26,135 35,608 (9,473) (26.6%) Net Contribution 4,657 8,868 (4,211) (47.5%) Net Contribution % 17.8% 24.9% (7.1%) • Total revenue -$9.5M vs PCP as previously explained • Comvita revenue

  25. Slide 25: Engagement & Affinity in North America

    FUNCTIONAL & EMOTIONAL Engagement & Affinity in North America REFRESHED BRAND EXPRESSION Product benefit focus = Digestion + Energy & Vitality + Immunity Emotional engagement = A few minutes’ “escape” + indulgent wellbeing COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY24 25

  26. Slide 26: Challenges & Actions: Lost Distribution in US

    FY24 Challenges & Actions LOST DISTRIBUTION IN US The issue Action to date • At the start of FY24 we lost some distribution with one of our biggest ✓ Strengthened the team, appointed a new Country Manager, customers strengthened online performance including Amazon (+61%) Context ✓ Refreshed brand co

  27. Slide 27: Industry Dynamics

    FY24 Industry Dynamics 27

  28. Slide 28: Volume of Honey Produced in New Zealand

    2000 – 2023 Volume of Honey Produced IN NEW ZEALAND Commentary • Hive numbers trebled between 2008 and 2019 peaking at c1M hives and exports grew by c500% • Created an industry overstock • Between 2020 and 2023 honey production has fallen by -56% • Ongoing supply now more aligned to demand, however,

  29. Slide 29: Comvita Owned Mānuka Forests

    FY22 – FY30 Comvita Owned Mānuka Forests • Comvita owned forests offer long term sustainable supply with cost advantages • 44% of apiary supply from our forest by 2030 and with a 20% saving in cost per hive will save us c$4M pa COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY24

  30. Slide 30: New Zealand Honey Export Value

    2002 – 2023 New Zealand Honey Export VAL U E Commentary • Exports grew five-fold between 2008 and 2017 • Exports reduced by -18% 2017 to 2019, +10% CAGR 2018 - 2021 • New Zealand honey export value has fallen by -26% from the peak in 2020 COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY24 30

  31. Slide 31: Honey Market

    FY24 Honey Market KEY DEMAND DYNAMICS • US is the biggest single market for Mono-floral honey. No dominant brand, Comvita currently lacks scale • China market number two globally, exports c3% CAGR since 2020, Comvita exports 15% CAGR since 2020. Comvita c54% market share in China • Aggressive price

  32. Slide 32: Summary

    Summary 32

  33. Slide 33: Summary

    FY24 Summary FY24 RESULT • FY24 revenue impacted by aforementioned challenges in all market segments • Exacerbated by short term price driven competition created by over supply • Underlying FY24 NPAT -$9.3M ACTION TAKEN • Comvita Good and Better range targeting value consumers and increased distribu

  34. Slide 34: Q+A

    Q+A 34

  35. Slide 35: Appendices

    Appendices 35

  36. Slide 36: Reconciliation of Impairment to $64M

    FY24 Reconciliation of Impairment to $64M Commentary 2024 In thousands of New Zealand dollars • The impairment as announced on 26 August of $59.8M together 30 June with the impairment taken up earlier associated with our Medibee 30,647 JV of $4.4M. Total FY24 impairment of $64.2M. Greater China – Go

  37. Slide 37: Delivering Environmental and Social Impact

    DELIVERING ENVIRONMENTAL AND SOCIAL Impact 37

  38. Slide 38: Global Whanau and Safety & Wellbeing

    PERFORMANCE VS PCP Global Whanau and Safety & Wellbeing 1 J U LY 2 0 2 3 – 3 0 J U N E 2 0 2 4 2.7 1.1 4.6pts S A F E TY MA TU R I T Y TR I F R L TI F R SCORE ↓ - 2 9 % vs F Y 2 3 ( 3 . 8 ) ↓ - 5 9 % vs F Y 2 3 ( 2 . 7 ) ↑ + 1 0 5 % vs F Y 2 3 ( 2 . 2 4 ) + 21 65% 100% E MP L O YE E P R O MO T E R O

  39. Slide 39: GHG Summary

    FY24 GLOBAL GHG Summary R E S U LT S GREENHOUSE GAS EMISSIONS – GLOBAL tCO2e FY24 FY23 Difference tCO2e tCO2e % Total Gross Emissions (S1,2,3)1 26,079 34,944 (25%) Removals GHG Inventory2 (1,488) (5,842) (75%) Total Net GHG Inventory Emissions 24,591 29,012 (16%) Comvita NZ ETS NZUs3 (3,730) (743) 4

  40. Slide 40: COMVITA.COM

    COMVITA.COM

Comvita — FY2024 Earnings Presentation on 6ix